4//SEC Filing
NANOVIRICIDES, INC. 4
Accession 0001144204-17-005838
$NNVCCIK 0001379006operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 1:25 PM ET
Size
9.1 KB
Accession
0001144204-17-005838
Insider Transaction Report
Form 4
BONIUK MILTON
Director
Transactions
- Other
Unsecured 8% Coupon Series B Convertible Debentures
2017-02-01−1→ 0 total(indirect: By Foundation)Exercise: $3.50From: 2013-02-01Exp: 2017-01-31→ Common Stock, par value $0.001 (571,428 underlying) - Other
Common Stock, par value $0.001 per share
2017-02-01−605,474→ 0 total(indirect: By Foundation)
Footnotes (4)
- [F1]Effective February 1, 2017, the Reporting Person no longer holds voting and dipositive control over the shares of common stock owned by Boniuk Charitable Foundation (the "Foundation") reported in this Form 4. This Form 4 solely reflects the relinquishment of that control by the Reporting Person. The Foundation is a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. No part of the Foundation's net income may inure to the benefit of the Reporting Person or any other private person, and the assets of the Foundation may not revert to private ownership if the Foundation is dissolved. Accordingly, the Reporting Person does not and did not have a pecuniary interest in the shares held by the Foundation and such shares no longer will be reported as beneficially owned by the Reporting Person for purposes of Section 16(a).
- [F2]Does not include: (a) 1,240,063 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife; (b) 309,844 shares of Common Stock, 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture, or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible; or (c) 976,902 shares of Common Stock , warrants to purchase an additional 285,714 shares of Common Stock, or an indeterminate number of shares of Common Stock issuable upon conversion of debentures held by Boniuk Interests, Ltd.; Dr. Boniuk holds voting and dispositive power over Boniuk Interests Ltd. and the Milton Boniuk IRA.
- [F3]Reflects the maturity date of debenture.
- [F4]Based upon the conversion price of $3.50.
Documents
Issuer
NANOVIRICIDES, INC.
CIK 0001379006
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001379006
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 1:25 PM ET
- Size
- 9.1 KB